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INTRODUCTION
AGel amyloidosis is an autosomal dominant form of systemic 
amyloidosis caused by pathogenic variants in the GSN gene.1 
AGel amyloidosis was first observed by the Finnish ophthal-
mologist Jouko Meretoja, and it is one of the most common ge-
Clinical Features and Brain MRI Findings 
in Korean Patients with AGel Amyloidosis
E-Nae Cheong1,2*, Wooyul Paik3*, Young-Chul Choi4, Young-Min Lim5, 
Hyunjin Kim5, Woo Hyun Shim1,2,6, and Hyung Jun Park4,7
1Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 
2Department of Medical Science and Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan 
College of Medicine, Seoul; 
Departments of 3Radiology and 7Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung; 
4Department of Neurology, Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University 
College of Medicine, Seoul; 
Departments of 5Neurology and 6Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Purpose: AGel amyloidosis is systemic amyloidosis caused by pathogenic variants in the GSN gene. In this study, we sought to 
characterize the clinical and brain magnetic resonance image (MRI) features of Korean patients with AGel amyloidosis.
Materials and Methods: We examined 13 patients with AGel amyloidosis from three unrelated families. Brain MRIs were per-
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VBM, TBSS, and FreeSurfer revealed no significant differences in cortical thickness between patients and healthy controls at the 
corrected significance level.
Conclusion: Our study outlines the clinical manifestations of prominent bulbar palsy and early-onset cutis laxa in 13 Korean pa-
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central nervous system.
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netic disorders of the Finnish disease heritage.2,3 There are two 
common pathogenic variants in the GSN gene (NM_000177.5: 
c.640G>A and c.640G>T). The c.640G>A variant (NP_000168.1: 
p.D214N) is the most common and has been observed in Fin-
land, Germany, Great Britain, Iran, Japan, Netherlands, Portu-
gal, Spain, Sweden, and the United States.4-13 The c.640G>T 
variant (NP_000168.1: p.D214Y) is less common and has been 
reported in Denmark, Brazil, Czechoslovakia, France, Korea, 
and the United States.5,14-18 
Typical clinical features of AGel amyloidosis include cranial 
and peripheral neuropathy, cutis laxa, and corneal lattice am-
yloidosis. The most common neurological symptoms are fa-
cial neuropathy and polyneuropathy, followed by myokymia, 
hearing impairment, carpal tunnel syndrome, ataxia, and dys-
arthria.3 However, a previous study reported severe bulbar dys-
function in one family with the c.640G>T variant.18 AGel amy-
loidosis is a systemic disease frequently involving the peripheral 
nervous system, and there have been few studies on its involve-
ment in the central nervous system.19,20 Therefore, we suspect 
that additional cerebral abnormalities, particularly in the corti-
cobulbar tract, may appear in patients with AGel amyloidosis. 
Recent advancements in the evaluation of the magnitude 
and directionality of water diffusion using diffusion tensor 
imaging (DTI) have made it possible to visualize nerve fiber 
orientation and the microstructural integrity of brain tissues. 
The use of quantitative measurements obtained using DTI 
can indicate the disruption of white matter (WM) integrity, 
which cannot be identified using conventional magnetic reso-
nance imaging (MRI) techniques.21,22 In addition, voxel-based 
morphometry (VBM) can be used to assess whole-brain mor-
phology using anatomical MRI without prior hypothesis about 
possible changes in a brain region. The VBM method can high-
light the intact and damaged areas of the brain by assigning a 
constant signal intensity value to each voxel and the associated 
neural differences in a target group. Therefore, DTI and VBM 
have been widely applied to investigate cerebral abnormalities 
in patients with various diseases, including Alzheimer’s disease, 
Parkinson’s disease, and neuromuscular disorders.23-27
Our study aimed to analyze the clinical and genetic features 
of Korean patients and to examine the presence of cerebral ab-
normalities in patients with AGel amyloidosis. Herein, we sum-
marized the clinical characteristics of 13 Korean patients with 
AGel amyloidosis. We also analyzed the extent of WM and gray 




We reviewed the medical records of Gangneung Asan Hospital 
from March 2018 to September 2019. In doing so, 13 patients 
from three unrelated families were found to have AGel amy-
loidosis (III-6, III-7, III-9, III-10, and III-14 from MF1531; II-6, 
III-2, III-3, IV-1, and IV-2 from MF1532; and III-2, III-3, and III-5 
from MF1533) (Fig. 1A). All patients had a pathogenic variant in 
GSN (NM_000177.5: c.640G>T; NP_000168.1: p.D214Y), which 
was completely co-segregated in the affected individuals from 
three families (Fig. 1B): this variant was previously identified 
as a pathogenic variant.28 We analyzed the clinical spectrum 
of the patients, including sex, age at diagnosis, age at symptom 
onset, and the presence of cutis laxa, drooping eyelids, cranial 
nerve functions, motor weakness, and sensory deficits. We ex-
amined eye movements in the nine cardinal positions of gaze. 
Motor weakness was evaluated by manual muscle testing. We 
also evaluated pain sense with a pin test, vibration sense with 
a 128-Hz tuning fork, and joint position sense at the interpha-
langeal joint of the big toe. Laboratory and radiological tests 
included slip lamp, nerve conduction, needle electromyogra-
phy, and brain MRI studies. The Institutional Review Board of 
Gangneung Asan Hospital approved the current study (ap-
proval number: 2019-06-040). All personal information was 
anonymously encrypted.
Brain MRI acquisition and analysis protocol
Eight patients with AGel amyloidosis and eight age- and sex-
matched healthy controls underwent brain MRI. The healthy 
controls did not present with any neuromuscular disorders 
and were referred to our hospital due to headaches. MRI data 
were obtained with a 3T scanner (Magnetom Skyra; Siemens, 
Munich, Germany) using a 20-channel head-neck coil. Based 
on the anatomical images of localization, T1-MPRAGE (TR: 
1810 ms, TE: 2.81 ms, and thickness: 1 mm) sagittal images and 
fluid-attenuated inversion recovery (FLAIR) (TR: 9,000 ms, TE: 
76 ms, and thickness: 5 mm) axial images covering the whole 
brain were acquired. Meanwhile, DTI data were obtained with 
a single-shot echo-planar imaging sequence (TR: 8,000 ms, TE: 
74 ms, matrix: 100×100, voxel size: 2.2×2.2×2.5 mm3, gradient 
orientations: 64, and b-value: 1,000 s/mm2). The measured raw 
DICOM data were converted into the NIFTI format using dc-
m2nii, which is part of the neuroimaging tool MRIcron.
VBM analysis
VBM was performed using SPM 12 (Wellcome Department of 
Cognitive Neurology, https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
FSLVBM) and the Diffeomorphic Anatomical Registration us-
ing Exponentiated Lie Algebra (DARTEL) registration meth-
od.29 Briefly, the T1-weighted images were segmented to produce 
tissue probability maps in the Montreal Neurological Institute 
(MNI) space: GM, WM, and cerebrospinal fluid. Then, DARTEL 
templates were created for registration and normalization 
from the individually segmented images. GM and WM images 
were then normalized to the DARTEL templates. Before statis-
tical calculation, the normalized images were smoothed with 
an 8-mm full-width half-maximum Gaussian filter to increase 
the signal-to-noise ratio. 
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SnPM 13 (Statistical NonParametric Mapping; http://nisox.
org/Software/SnPM13/) with 5000 permutations without 
variance smoothing was used to compare voxel-wise differ-
ences in GM volumes between the patients with AGel amyloi-
dosis and healthy controls. Analyses were performed using a 
linear regression model considering age, sex, and total intra-
cranial volume as covariates. Significant differences were iden-
tified using a false discovery rate (FDR)-corrected threshold of 
p<0.05 and an uncorrected threshold of p<0.001 (t>3.69).
Analysis of tract-based spatial statistics 
The processing of diffusion tensor images was performed using 
software tools from the FMRIB software library (FSL, http://
www.fmrib.ox.ac.uk/fsl). Then, a voxel-wise statistical analy-
sis of fractional anisotropy (FA) data was performed using 
tract-based spatial statistics (TBSS), which is a part of the FSL. 
Head motion and eddy currents were corrected using the ref-
erence B0 image. In addition, brain extraction was conducted 
using the Brain Extraction Tool (a part of FSL). Then, the diffu-
sion tensors were calculated using three b values and gradient 
directions, and FA maps were finally produced. These were re-
ferred to as the preprocessing stages. Next, FA data were aligned 
into MNI Space using the FMRIB’s Nonlinear Image Registra-
tion Tool. Then, the mean FA image (threshold of 0.2) was creat-
ed and thinned to establish a mean FA skeleton that represents 
the centers of all tracts common to the group. Each subject’s 
aligned FA data were then projected onto this skeleton, and the 
resulting data were fed into voxel-wise cross-subject statistics. 
We used 5000 permutations per test, and threshold-free clus-
ter enhancement was used to enhance cluster-like structures 
without the need for preset clustering thresholds. FDR-correct-
ed p values<0.05 and uncorrected p values<0.05 were consid-
ered statistically significant. 
Analysis of cortical thickness 
Cortical thickness analysis was performed with the FreeSurfer 
software (version 6.0; http://surfer.nmr. mgh.harvard.edu) us-
ing the “recon-all” processing stream. The implemented pro-
cessing stream included the removal of non-brain tissue, au-
tomated Talairach transformation, normalized intensity, 
tessellation of GM/WM boundaries, automated topology cor-
rection, and surface deformation. Then, the cerebral cortex 
MF1531














Fig. 1. Pedigree and sequencing chromatograms of three families with AGel amyloidosis. (A) Pedigree of the three families with AGel amyloidosis. Aster-
isks (*) indicate individuals who participated in the current study. Genotypes of GSN (c.640 G>T) are shown under each subject (arrow, proband; square, 
male; circle, female; filled, affected; not filled, unaffected; diagonal bar across the symbol, deceased). (B) Sequencing chromatograms of the c.640G>A 
pathogenic variant in GSN. This heterozygous variant was completely co-segregated in the affected individuals from three families and was previously 
identified and classified as a pathogenic variant. 
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was parcellated into the anatomical structures. Cortical thick-
ness was computed by finding the shortest distance between 
a given point on the estimated pial surface and the GM/WM 
boundary. The thickness measurement of each vertex of the 
subjects’ surface was mapped on a standard spherical coordi-
nate system. The vertex-wise general linear model was applied 
for group comparison of the cerebral cortical thickness be-
tween patients and healthy controls using the FreeSurfer “qdec” 
tool after surface-based smoothing of 10 mm FWHM. Age and 
sex were used as covariates in the models. For all comparisons, 
an FDR correction for multiple comparisons across space was 
applied. FDR-corrected p values<0.05 were considered statis-
tically significant.
RESULTS
Clinical presentation of Korean patients with AGel 
amyloidosis
Three index patients (III-9 from MF1531, III-2 from MF1532, 
and III-5 from MF1533) were referred to our neurology clinic 
due to dysarthria and dysphagia. Table 1 shows the demo-
graphic and clinical characteristics of 13 patients from three 
unrelated families. The median age at examination was 73 (in-
terquartile range: 64–76) years. The median age at onset of cu-
tis laxa was 20 (interquartile range: 15–30) years. Cutis laxa was 
found in all patients. All patients first noticed their loose skin 
on the scalp when they had their haircut, especially when us-
ing hair clippers as teenagers. All patients aged over 60 years 
complained of drooping eyelids. Patients reported that their 
eyelids began drooping at the median age of 52 (interquartile 
range: 51–60) years. Among them, five patients (III-6, III-7, and 
III-9 from MF1531; III-3 from MF1532; and III-5 from MF1533) 
had blepharoplasty with or without rhytidectomy at 55, 57, 53, 
48, and 62 years old, respectively. All patients aged over 60 
years complained of dysarthria, drooling, and dysphagia. The 
median age at dysarthria onset was 66 (interquartile range: 
63.5–70) years. Five patients complained of decreased visual 
acuity that presented in their 30s. However, analysis using a slip 
lamp revealed abnormal deposits on the cornea in seven pa-
tients, including two asymptomatic patients, who were tested. 
Based on physical examination, eleven patients aged over 60 
years had loose facial skin, facial muscle weakness, and tongue 
atrophy (Fig. 2). Ophthalmoparesis was observed in three pa-
tients. The impairment of joint position sense and vibration 
sense were found in five patients. However, all patients did not 
present with muscle weakness of the limbs. Two patients (IV-1 
and IV-2) in their 30s had only mild cutis laxa on their face and 
scalp (Supplementary Fig. 1, only online). Physical examina-
tion and needle electromyography also did not show any ab-
normalities in the tongue and facial muscles of two patients in 
their 30s. Ten patients underwent nerve conduction studies and 
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tients presented with sensory polyneuropathy, three with car-
pal tunnel syndrome, and two with axonal sensorimotor poly-
neuropathy. Meanwhile, two patients had normal study results. 
In addition, eight patients aged over 60 years showed chronic 
neurogenic process of the tongue and facial muscles.
Brain MRI findings of Korean patients with AGel 
amyloidosis
Eight patients aged over 60 years who had AGel amyloidosis 
and eight age- and sex-matched healthy controls underwent 
MRI. Axial FLAIR images of the brain showed no significant 
difference between the patients and healthy controls (Fig. 3). 
In VBM analysis, the patients had a significant loss of the right 
middle occipital gyrus, superior frontal gyrus, middle frontal 
gyrus, and left cerebellum (culmen), compared to healthy 
controls (p < 0.001, uncorrected) (Supplementary Fig. 2, only 
online). However, there was no significant difference between 
the patients and healthy controls at the corrected significance 
level. Based on the voxel-wise TBSS analysis, the patients had 
significantly lower FA values than healthy controls. The results 
are shown in Supplementary Fig. 3 (only online) (p<0.05, un-
corrected). However, there was no difference in FDR-correct-
ed results between the two groups. The FreeSurfer analysis 
did not show any significant difference in cortical thickness 
between the patients and healthy controls at both uncorrect-
ed and corrected significance levels.
DISCUSSION
Our study outlines the clinical characteristics and brain struc-
tural abnormalities among Korean patients with AGel amyloi-
dosis, in which the cranial and peripheral nerves were mainly 
affected. In addition, this study assessed the brain parenchy-
mal abnormalities among patients with AGel amyloidosis using 
the VBM, TBSS, and FreeSurfer (cortical thickness measure-
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ments) techniques.
Our patients had the same pathogenic variant in the GSN 
gene (NM_000177.5: c.640G>T; NP_000168.1: p.D214Y). In 
previous literature, this amino acid change was historically re-
ferred to as p.D187Y (www.omim.org/entry/137350#0002).5 
This pathogenic variant is the same variant previously report-
ed in Korean patients with AGel amyloidosis.16,17 Two main 
pathogenic variants (c.640G>A and c.640G>T) affect the same 
codon. The central hypothesis is as follows: these pathogenic 
variants result in aberrant conformational changes and dis-
rupt the Ca2+ binding capacity of the gelsolin protein. This al-
teration leads to aberrant furin cleavage in the trans-Golgi 
network and triggers the proteolytic pathway producing amy-
loidogenic fragments.30,31 A recent study also showed that the 
D214N AGel protein under Ca2+-depletion and a low pH con-
dition can induce amyloid-like assembly without the specific 
proteolytic step.32 However, although alterations in the GSN 
gene do not always result in systemic amyloidosis, some have 
been shown to cause renal amyloidosis. Two pathogenic vari-
ants (c.580G>A and c.633C>A) were observed in renal amyloi-
dosis without dermatologic, neurological, and ophthalmologic 
abnormalities.33,34 Therefore, further studies must be conduct-
ed to determine the pathological mechanism by which the 
variants in the GSN gene cause the clinical phenotype.
Our patients showed prominent bulbar palsy and early-on-
set cutis laxa. Prominent bulbar palsy is not a common feature 
in patients with the c.640G>A variant.3 For example, dysar-
thria, a typical symptom of bulbar palsy, was observed in only 
61 (27%) of 227 Finish patients with the c.640G>A variant.3 
However, 11 (65%) of 17 patients with the c.640G>T variant had 
dysarthria, dysphagia, or tongue atrophy.14,15,18,35,36 Therefore, 
prominent bulbar palsy could be considered a characteristic 
finding of patients with the c.640G>T variant, like our patients. 
Early-onset cutis laxa was not previously reported in studies 
from other countries.4-15,18,35,36 The age at onset of cutis laxa was 
based on the patient’s memory. However, the patients first no-
ticed their loose scalp when they cut their hair using hair clip-
pers as teenagers. Moreover, we found cutis laxa of the face in 
two patients in their 30s. Further studies are needed regarding 
this finding. Only 38% of the patients complained of decreased 
visual acuity. However, analysis using a slip lamp revealed cor-
neal dystrophy in all tested patients. Ophthalmoparesis was not 
found in Korean patients, but was previously observed in pa-
tients with AGel amyloidois.37 
Our study showed no significant differences in cerebral ab-
normalities between the patients and healthy controls (FDR-
corrected p<0.05). To date, few studies have assessed brain 
damage in patients with AGel amyloidosis.19,20,38 Among them, 
Fig. 3. Axial fluid-attenuated inversion recovery MR images of III-6 patient from MF1531 and age- and sex-matched healthy controls. There were no 
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one study revealed frontal leukoencephalopathy, as well as peri-
ventricular and intrapontine high signal intensities, on brain 
MRI.38 Other studies also showed cerebral amyloid angiopathy 
in autopsy cases.19,20 To confirm these differences, we analyzed 
multimodal structural brain images: VBM, TBSS, and FreeSurf-
er. However, none of the anatomical brain analyses revealed a 
significant loss of GM and WM in patients. For uncorrected re-
sults, the analysis of VBM and TBSS showed the loss of several 
cerebral regions in patients. However, there were no significant 
differences between the patients and healthy controls at the 
corrected significance level. Additionally, the reduced regions 
in patients at uncorrected results were not associated with the 
neurological deficits of AGel amyloidosis. Therefore, we did 
not find additional cerebral abnormalities associated with cra-
nial neuropathy of AGel amyloidosis. Together with previous 
studies, our results suggest that there were less cerebral abnor-
malities rather than no involvement. 
Our study had a significant limitation of including only a 
small number of patients with AGel amyloidosis. We analyzed 
the clinical information of 13 patients with AGel amyloidosis 
and brain MRI findings of eight patients. Since AGel amyloi-
dosis is a rare genetic disease, it was only observed in two Ko-
rean patients previously.16,17 To overcome this limitation, we 
included age- and sex-matched healthy controls. However, 
further stud¬ies with a larger cohort must be conducted to val-
idate the consistency of our results.
In conclusion, this study outlined the characteristic clinical 
manifestations of prominent bulbar palsy and early-onset cu-
tis laxa in 13 Korean patients with AGel amyloidosis. Addi-
tionally, we confirmed that AGel amyloidosis mainly affected 
the peripheral nervous system rather than the central nervous 
system. 
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